@tuts, bit confused mate, wonder if you can help......As Aipac...

@tuts, bit confused mate, wonder if you can help......
As Aipac is progressive enrolment with treatment commencing on enrolment ......
So some have been treated much longer than the last to enrol...

OK...from the announcement....

• Progression Free Survival (PFS) Hazard Ratio improvement for eftilagimod alpha (efti) group versus
placebo at the 6-month landmark....

SO

How is the 6 month landmark determined when patients have been treated for varying lengths of time?

Also

that to me means some patients have presumably been treated for 2 years varying down to say 9 months (guess)
so theoretically there should be way more data available than has been released?
I note: midpoint of enrolment n113 in 2018...

My lack of medical knowledge is on show here but I think you"ll get where I'm coming from if you have the time...